Glomerular hyperfiltration in microalbuminuric NIDDM patients

Diabetologia
P VedelH H Parving

Abstract

Glomerular hyperfiltration and microalbuminuria are both regarded as risk factors for the development of diabetic nephropathy in insulin-dependent diabetic patients. Information on glomerular hyperfiltration is scarce in microalbuminuric non-insulin-dependent diabetic (NIDDM) patients. Therefore, we performed a cross-sectional study of glomerular filtration rate (single i.v. bolus injection of 51Cr-EDTA, plasma clearance for 4 h) in 158 microalbuminuric NIDDM patients compared to 39 normoalbuminuric NIDDM patients and 20 non-diabetic control subjects. The groups were well-matched with regard to sex, age and body mass index. The uncorrected (ml/min) and the adjusted (ml. min-1. 1.73 m-2) glomerular filtration rate were both clearly elevated in the microalbuminuric patients: 139 +/- 29 and 117 +/- 24 as compared to 115 +/- 19 and 99 +/- 15; 111 +/- 23 and 98 +/- 21 in normoalbuminuric NIDDM patients and control subjects, respectively (p < 0.001). The glomerular filtration rate (ml. min-1. 1.73 m-2) in NIDDM patients who had never received antihypertensive treatment was also clearly elevated in the microalbuminuric patients (n = 96): 119 +/- 22 as compared to 100 +/- 14 and 98 +/- 21 in normoalbuminuric NIDDM patients (n = 27) and...Continue Reading

Citations

May 25, 2010·Diabetologia·G JerumsR J MacIsaac
Nov 13, 2003·Current Diabetes Reports·Ruth C CampbellGiuseppe Remuzzi
Oct 30, 2003·Journal of Diabetes and Its Complications·Saliha Apakkan AksunOya Bayindir
Feb 4, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Menno PruijmMichel Burnier
Apr 1, 2010·Nephrology·S ChadbanUNKNOWN CARI
Feb 5, 2011·Nephron. Clinical Practice·David K PackhamUNKNOWN Collaborative Study Group
Aug 29, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Hiroki YokoyamaMasakazu Haneda
Feb 27, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Jean-Philippe HaymannFrançois Lionnet
Oct 22, 2011·Diabetes Research and Clinical Practice·Wen-Jin FuQian Wang
Aug 6, 2016·Journal of Cachexia, Sarcopenia and Muscle·Shuo-Ming OuUNKNOWN Taiwan Geriatric Kidney Disease (TGKD) Research Group
Mar 18, 2008·Diabetes Research and Clinical Practice·Tatsumi MoriyaYoshikuni Fujita
Jun 3, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E BelloS Casado
Aug 30, 2005·Diabetes Research and Clinical Practice·Yasuyuki JinYoshikuni Fujita
Aug 17, 2004·American Heart Journal·Peter A McCulloughRobert M Califf
Mar 15, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Rafael N MorescoGuilherme V Bochi
Dec 3, 2014·Diabetes & Metabolism·E PremaratneR J MacIsaac
Nov 25, 2003·Diabetes Care·Steen AndersenUNKNOWN Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria Study Group
Jan 6, 2006·Journal of the American Society of Nephrology : JASN·M Luiza CaramoriMichael Mauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.